PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer

A Glaviano, ASC Foo, HY Lam, KCH Yap, W Jacot… - Molecular cancer, 2023 - Springer
Abstract The PI3K/AKT/mTOR (PAM) signaling pathway is a highly conserved signal
transduction network in eukaryotic cells that promotes cell survival, cell growth, and cell …

Metabolic reprogramming induces macrophage polarization in the tumor microenvironment

S Wang, G Liu, Y Li, Y Pan - Frontiers in immunology, 2022 - frontiersin.org
Macrophages are one of the most important cells in the innate immune system, they are
converted into two distinct subtypes with completely different molecular phenotypes and …

Metabolic reprogramming in macrophage responses

Y Liu, R Xu, H Gu, E Zhang, J Qu, W Cao, X Huang… - Biomarker …, 2021 - Springer
Macrophages are critical mediators of tissue homeostasis, with the function of tissue
development and repair, but also in defense against pathogens. Tumor-associated …

An update on rhabdomyosarcoma risk stratification and the rationale for current and future Children's Oncology Group clinical trials

JH Haduong, CM Heske… - Pediatric blood & …, 2022 - Wiley Online Library
Children and adolescents with rhabdomyosarcoma (RMS) comprise a heterogeneous
population with variable overall survival rates ranging between approximately 6% and 100 …

Recent progress in the treatment of cancer in children

E Butler, K Ludwig, HL Pacenta… - CA: a cancer journal …, 2021 - Wiley Online Library
Although significant improvements have been made in the outcomes of children with cancer,
the pace of improvement has slowed in recent years as the limits of therapy intensification …

Autophagy in health and disease: From molecular mechanisms to therapeutic target

G Lu, Y Wang, Y Shi, Z Zhang, C Huang, W He… - MedComm, 2022 - Wiley Online Library
Macroautophagy/autophagy is an evolutionally conserved catabolic process in which
cytosolic contents, such as aggregated proteins, dysfunctional organelle, or invading …

Randomized phase II trial of vincristine-irinotecan with or without temozolomide, in children and adults with relapsed or refractory rhabdomyosarcoma: A European …

AS Defachelles, E Bogart, M Casanova… - Journal of Clinical …, 2021 - ascopubs.org
PURPOSE The VIT-0910 trial was conducted to evaluate efficacy and safety of the
vincristine-irinotecan combination with and without temozolomide (VIT and VI, respectively) …

Rhabdomyosarcoma: current therapy, challenges, and future approaches to treatment strategies

A Zarrabi, D Perrin, M Kavoosi, M Sommer, S Sezen… - Cancers, 2023 - mdpi.com
Simple Summary Rhabdomyosarcoma (RMS) is a rare pediatric sarcoma affecting skeletal
muscle in children and young adults. It is responsible for 3% of all childhood malignant …

Triggered release from thermosensitive liposomes improves tumor targeting of vinorelbine

M Regenold, K Kaneko, X Wang, HB Peng… - Journal of Controlled …, 2023 - Elsevier
Triggered drug delivery strategies have been shown to enhance drug accumulation at target
diseased sites in comparison to administration of free drug. In particular, many studies have …

Relapsed rhabdomyosarcoma

CM Heske, L Mascarenhas - Journal of clinical medicine, 2021 - mdpi.com
Relapsed rhabdomyosarcoma (RMS) represents a significant therapeutic challenge. Nearly
one-third of patients diagnosed with localized RMS and over two-thirds of patients with …